IS4261A - Nýir peptíð-ópíóíðar til meðhöndlunar á verkjum og notkun þeirra - Google Patents

Nýir peptíð-ópíóíðar til meðhöndlunar á verkjum og notkun þeirra

Info

Publication number
IS4261A
IS4261A IS4261A IS4261A IS4261A IS 4261 A IS4261 A IS 4261A IS 4261 A IS4261 A IS 4261A IS 4261 A IS4261 A IS 4261A IS 4261 A IS4261 A IS 4261A
Authority
IS
Iceland
Prior art keywords
peptides
pain
treatment
opioid
compositions
Prior art date
Application number
IS4261A
Other languages
English (en)
Inventor
Brown William
Dimaio John
Schiller Peter
Martel René
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9403263A external-priority patent/GB9403263D0/en
Priority claimed from SE9401519A external-priority patent/SE9401519D0/xx
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of IS4261A publication Critical patent/IS4261A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
IS4261A 1994-02-21 1995-02-13 Nýir peptíð-ópíóíðar til meðhöndlunar á verkjum og notkun þeirra IS4261A (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9403263A GB9403263D0 (en) 1994-02-21 1994-02-21 Novel opiod peptides
GB9408179A GB9408179D0 (en) 1994-02-21 1994-04-25 Novel opioid peptides for the treatment of pain and use thereof
SE9401519A SE9401519D0 (sv) 1994-05-03 1994-05-03 Novel opioid peptides for the tratment of pain and use thereof

Publications (1)

Publication Number Publication Date
IS4261A true IS4261A (is) 1995-08-22

Family

ID=27267061

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4261A IS4261A (is) 1994-02-21 1995-02-13 Nýir peptíð-ópíóíðar til meðhöndlunar á verkjum og notkun þeirra

Country Status (20)

Country Link
EP (1) EP0746567B1 (is)
JP (1) JPH09509168A (is)
AT (1) ATE217011T1 (is)
BR (1) BR9506847A (is)
CA (1) CA2181367A1 (is)
CZ (1) CZ288523B6 (is)
DE (1) DE69526577T2 (is)
EE (1) EE03265B1 (is)
ES (1) ES2176322T3 (is)
FI (1) FI963252A0 (is)
HR (1) HRP950413A2 (is)
HU (1) HUT74731A (is)
IS (1) IS4261A (is)
MX (1) MX9603489A (is)
NO (1) NO963464L (is)
NZ (1) NZ281742A (is)
PL (1) PL181092B1 (is)
SK (1) SK93596A3 (is)
TW (1) TW408131B (is)
WO (1) WO1995022557A1 (is)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9503924D0 (sv) * 1995-08-18 1995-11-07 Astra Ab Novel opioid peptides
ES2180781T3 (es) * 1995-06-07 2003-02-16 Torrey Pines Inst Nuevos ligandos del receptor opiaceo mu: agonistas y antagonistas.
GB9516994D0 (en) * 1995-08-18 1995-10-18 Iaf Biochem Int Solution synthesis of peripheral acting analgestic opioid tetrapeptides
MX9709494A (es) * 1996-12-04 1998-07-31 Pfizer Compuestos peptidicos ciclicos, procedimiento para su produccion, composiciones que los contienen y uso de los mismos.
US5885958A (en) 1997-03-25 1999-03-23 Administrators Of The Tulane Educational Fund Mu-opiate receptor peptides
WO1999065932A1 (en) * 1998-06-18 1999-12-23 Sepracor, Inc. Tetrapeptides, analogs and peptidomimetics which bind selectively mammalian opioid receptors
SE9900961D0 (sv) * 1999-03-16 1999-03-16 Astra Ab Novel compounds
US7115664B2 (en) 2000-03-16 2006-10-03 Sepracor Inc. Peptidomimetic ligands for cellular receptors and ion channels
CA2416475C (en) 2000-07-18 2011-10-11 Cornell Research Foundation, Inc. Medicinal uses of mu-opioid receptor agonists
SI2656854T1 (sl) 2003-02-04 2015-09-30 Cornell Research Foundation, Inc. Uporabe aromatsko-kationskega peptida
KR101161823B1 (ko) 2003-05-01 2012-07-03 코넬 리서치 화운데이션,인크. 세포로 분자를 전달하는 방법 및 이것을 위한 캐리어 복합체
NZ549393A (en) 2004-01-23 2009-07-31 Cornell Res Foundation Inc Methods for reducing oxidative damage
CN101166524B (zh) 2005-04-28 2010-12-22 辉瑞有限公司 氨基酸衍生物
CN103784937B (zh) 2005-09-16 2017-04-26 科内尔研究基金会 用于减少cd36表达的方法
EP1782819A1 (en) 2005-11-03 2007-05-09 Cognis IP Management GmbH Oligopeptides and their use
US8906859B2 (en) 2006-11-10 2014-12-09 Cera Therapeutics, Inc. Uses of kappa opioid synthetic peptide amides
US8236766B2 (en) 2006-11-10 2012-08-07 Cara Therapeutics, Inc. Uses of synthetic peptide amides
US7842662B2 (en) 2006-11-10 2010-11-30 Cara Therapeutics, Inc. Synthetic peptide amide dimers
WO2008057608A2 (en) 2006-11-10 2008-05-15 Cara Therapeutics, Inc. Synthetic peptide amides
US7713937B2 (en) 2006-11-10 2010-05-11 Cara Therapeutics, Inc. Synthetic peptide amides and dimeric forms thereof
CN102127152B (zh) * 2007-06-11 2012-07-04 北京大学 一种抗阿片肽的拮抗肽与该拮抗肽的应用
CN102127151B (zh) * 2007-06-11 2012-07-04 北京大学 抗阿片肽的拮抗肽与该拮抗肽的应用
CN101805396B (zh) * 2007-06-28 2011-09-14 北京大学 抗阿片肽的拮抗肽与该拮抗肽的应用
CN101817877B (zh) * 2007-06-28 2011-09-14 北京大学 一种抗阿片肽的活性片段
CN101939019B (zh) 2008-02-07 2014-07-16 康奈尔大学 用于预防或治疗胰岛素抵抗性的方法
EP2262520B1 (en) 2008-02-26 2017-05-03 Cornell University Compositions for prevention and treatment of renal injury
JP2021525736A (ja) * 2018-05-31 2021-09-27 ザ・ユニバーシティ・オブ・シドニー 鎮痛剤及びその使用の方法
CN113968902B (zh) * 2020-07-25 2023-05-26 兰州大学 亮氨酸-脑啡肽类似物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8005121A (nl) * 1979-09-20 1981-03-24 Erba Farmitalia Biologisch actieve peptiden.
NZ258345A (en) * 1992-11-12 1996-03-26 Biomeasure Inc Peptides (opioid) capable of selectively binding to cell receptors
SE9300012D0 (sv) * 1993-01-05 1993-01-05 Astra Ab New peptides

Also Published As

Publication number Publication date
WO1995022557A1 (en) 1995-08-24
HRP950413A2 (en) 1997-10-31
BR9506847A (pt) 1997-09-30
NO963464L (no) 1996-08-20
DE69526577D1 (de) 2002-06-06
AU690648B2 (en) 1998-04-30
CZ288523B6 (cs) 2001-07-11
TW408131B (en) 2000-10-11
HU9602281D0 (en) 1996-10-28
FI963252A (fi) 1996-08-20
NZ281742A (en) 1997-06-24
AU1865195A (en) 1995-09-04
ATE217011T1 (de) 2002-05-15
DE69526577T2 (de) 2003-01-02
SK93596A3 (en) 1997-05-07
PL315947A1 (en) 1996-12-09
HUT74731A (en) 1997-02-28
EE03265B1 (et) 2000-04-17
MX9603489A (es) 1997-03-29
CZ239196A3 (en) 1996-12-11
CA2181367A1 (en) 1995-08-24
FI963252A0 (fi) 1996-08-20
EP0746567A1 (en) 1996-12-11
EP0746567B1 (en) 2002-05-02
ES2176322T3 (es) 2002-12-01
JPH09509168A (ja) 1997-09-16
PL181092B1 (pl) 2001-05-31

Similar Documents

Publication Publication Date Title
IS4261A (is) Nýir peptíð-ópíóíðar til meðhöndlunar á verkjum og notkun þeirra
SE9503924D0 (sv) Novel opioid peptides
DE69627690T2 (de) Liposomale formulierungen von mitoxantron
ZA975437B (en) New pyridyl alkene and pyridyl alkine acid amides.
AP2000001785A0 (en) Medicaments
DE60134453D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung von ZNS und anderen Krankheiten
DE60126980D1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
BRPI9708566A (pt) Análogo de glp-2, análogo de peptìdeo glp-humano, peptìdeo, composição farmacêutica, uso de um análogo de glp-2, e, processo para identificar análogos intestinotróficos de glp-2.
ATE338771T1 (de) Antagonisten des intestinotrophen glp-2 peptides
NZ334270A (en) Glucagon like peptide (GLP-1), analogs and derivatives to treat post surgical catabolic changes and insulin resistance
HU9602522D0 (en) Heterocyclic compounds, their preparation and use
HUP0101546A2 (hu) Opioid antagonistát és NMDA-receptor komplex modulátort tartalmazó gyógyászati készítmény alkohol- és drogfüggőség kezelésére
ES2174337T3 (es) Uso topico de los agonistas opioides kappa para el tratamiento del dolor ocular.
BG104179A (en) Phanquinon administration for the treatment of the alzheimer's disease
SE9902597D0 (sv) New use
EP1164141A3 (en) Opioid peptides and their use for treatment of pain
TR199901385T2 (xx) Piperidin t�revleri.
SE9502877D0 (sv) Novel opioid peptides
PT907737E (pt) Muteina da il-6
YU55095A (sh) Novi opioidni peptidi za lečenje bola i njihova primena novel
UA22223A (uk) Спосіб лікуваhhя захворюваhь оргаhа зору
TH48583A (th) สารผสมสำหรับชักนำการเจริญ
RU99107828A (ru) Способ лечения патологического влечения к наркотикам у больных опийной наркоманией
RU98114769A (ru) Способ повышения вестибулярной устойчивости человека
RU97112616A (ru) Лекарственный препарат для лечения проктологических заболеваний